Flattish volume growth and subdued new launches were key factors for last month
India Ratings and Research (Ind-Ra) highlights that the Indian pharmaceutical market (IPM) continued to deliver slow growth of 6.6% yoy in November 2021 compared to 5.0% in October 2021, led by flattish volume growth and subdued new launches. The acute therapy segment performed lower than sub-chronic and chronic segments in November 2021.
Ind-Ra highlights that the acute segment has been showing a robust performance since March 2021 (average growth at 29% yoy). Post normalisation of the high growth months of April 2021 (51.5% growth) and May 2021 (47.8%) led by the lockdown related lower base last year and higher volume growth, the average IPM growth from June to November 2021 has been healthy (11.6% yoy). In terms of growth drivers, the price growth, new product launches growth and volume growth stood at 5.6%, 3.3% and 6.3% yoy, respectively, which led to overall IPM size of INR1,664 billion in November 2021 (October 2021: INR1,656 billion).
Acute Therapies Reported Slower Growth than Chronic Ones: The acute therapy segment reported sales growth of 6.0% yoy (October 2021: 8.1% yoy; September 2021: 17.3% yoy), while chronic and sub-chronic therapy segments reported growth at 7.2% yoy (1.9% yoy; 7.4% yoy) and 6.7% yoy (2.9%; 8.9%), respectively, in November 2021. During FY21, the acute therapy segment reported negative growth on account of COVID-19 while the chronic therapy segment reported average growth of 7.0% in the same period.
Top Five Therapies Contribution stood at 57% of IPM: These therapies are cardiac (chronic; 13.0% of IPM), anti-infectives (acute; 14.3%), gastro-intestinal (acute; 11.6%), anti-diabetic (chronic; 9.4%) and vitamins (acute; 9.0%).
|
|
|||||||
|
Company/Therapy; INR million |
MAT Nov 21 |
Growth yoy |
% total |
Nov 21 |
Nov 20 |
Nov 19 |
Nov 18 |
|
Cardiac |
|||||||
|
Sun |
23,092 |
7.9 |
10.7 |
2,056 |
1,725 |
1,654 |
1,611 |
|
Torrent |
15,500 |
7.0 |
7.2 |
1,315 |
1,161 |
1,138 |
1,005 |
|
Lupin |
15,342 |
10.6 |
7.1 |
1,218 |
1,175 |
1,048 |
942 |
|
Usv |
10,576 |
7.8 |
4.9 |
913 |
821 |
796 |
702 |
|
Emcure |
10,200 |
28.2 |
4.7 |
684 |
779 |
601 |
526 |
|
Anti-Infectives |
|||||||
|
Aristo |
23,229 |
39.6 |
9.8 |
1,855 |
1,593 |
1,670 |
1,237 |
|
Alkem |
21,532 |
18.5 |
9.0 |
1,649 |
1,739 |
1,832 |
1,538 |
|
Cipla |
20,520 |
29.3 |
8.6 |
1,492 |
1,776 |
1,305 |
1,163 |
|
Macleods |
16,227 |
46.1 |
6.8 |
1,390 |
1,103 |
1,109 |
938 |
|
Mankind |
14,864 |
18.2 |
6.2 |
1,245 |
1,055 |
1,275 |
1,016 |
|
Gastro Intestinal |
|||||||
|
Abbott |
21,064 |
28.9 |
10.9 |
1,797 |
1,474 |
1,358 |
1,132 |
|
Sun |
16,833 |
20.1 |
8.7 |
1,472 |
1,245 |
1,228 |
1,070 |
|
Alkem |
10,676 |
15.8 |
5.5 |
866 |
803 |
730 |
685 |
|
Aristo |
9,612 |
30.2 |
5.0 |
773 |
657 |
563 |
451 |
|
Torrent |
9,274 |
28.4 |
4.8 |
812 |
648 |
586 |
493 |
|
Anti-Diabetic |
|||||||
|
Abbott |
19,483 |
10.4 |
12.4 |
1,648 |
1,495 |
1,529 |
1,432 |
|
USV |
14,811 |
2.4 |
9.4 |
1,206 |
1,198 |
1,196 |
1,140 |
|
Lupin |
13,770 |
1.4 |
8.8 |
1,049 |
1,152 |
1,036 |
906 |
|
Sun |
11,541 |
1.9 |
7.4 |
1,006 |
923 |
914 |
852 |
|
Sanofi India |
10,682 |
8.0 |
6.8 |
872 |
779 |
782 |
777 |
|
Vitamins / Minerals / Nutrients |
|||||||
|
Abbott |
11,647 |
11.5 |
7.8 |
815 |
958 |
767 |
678 |
|
Mankind |
9,434 |
15.0 |
6.3 |
745 |
672 |
708 |
599 |
|
Alkem |
8,410 |
18.6 |
5.6 |
614 |
663 |
542 |
491 |
|
Torrent |
6,740 |
17.4 |
4.5 |
562 |
478 |
462 |
415 |
|
Sun |
6,377 |
25.7 |
4.3 |
540 |
480 |
406 |
331 |
|
Source: AIOCD-AWACS, Ind-Ra |
|||||||
|
Performance of Top Five Group Class in Top Five Therapies in IPM |
|||||||
|
Therapy/group names; INR million |
MAT Nov 21 |
Growth yoy |
% total |
Nov 21 |
Nov 20 |
Nov 19 |
Nov 18 |
|
Cardiac |
2,16,157 |
9.5 |
100.0 |
17,751 |
16,697 |
15,428 |
13,691 |
|
Statins |
21,184 |
6.9 |
9.8 |
1,821 |
1,619 |
1,575 |
1,412 |
|
Platelet Aggregation Inhibitors |
16,082 |
11.8 |
7.4 |
1,437 |
1,208 |
1,126 |
1,019 |
|
Beta-Blocking Agents, Plain |
15,994 |
7.9 |
7.4 |
1,357 |
1,266 |
1,166 |
1,074 |
|
Angiotensin Ii Antagonists + Diuretics |
15,864 |
-1.9 |
7.3 |
1,270 |
1,300 |
1,305 |
1,163 |
|
Angiotensin-Ii Antagonists, Plain |
15,047 |
-3.1 |
7.0 |
1,184 |
1,263 |
1,236 |
1,096 |
|
Anti-Infectives |
2,38,045 |
26.4 |
100.0 |
18,052 |
18,251 |
18,115 |
15,497 |
|
Cephalosporins |
77,649 |
26.9 |
32.6 |
6,457 |
5,558 |
6,636 |
5,482 |
|
Broad Spectrum Penicillins |
30,577 |
14.9 |
12.8 |
2,862 |
2,339 |
2,833 |
2,295 |
|
Antivirals, Excluding HIV Products |
23,177 |
36.5 |
9.7 |
828 |
2,371 |
896 |
1,111 |
|
Macrolides And Similar Types |
21,157 |
20.5 |
8.9 |
1,651 |
1,649 |
1,654 |
1,351 |
|
Systemic Agents For Fungal Infections |
18,251 |
17.5 |
7.7 |
1,292 |
1,412 |
1,586 |
1,362 |
|
Gastro Intestinal |
1,93,487 |
21.5 |
100.0 |
15,692 |
13,877 |
13,446 |
11,825 |
|
Gastroprokinetics |
42,219 |
18.2 |
21.8 |
3,520 |
3,180 |
3,025 |
2,699 |
|
Anti-Ulcerants Acid Pump Inhibitors |
23,670 |
17.6 |
12.2 |
1,942 |
1,750 |
1,781 |
1,473 |
|
Antidiarrhoeal Micro-Organisms |
13,069 |
35.8 |
6.8 |
1,012 |
817 |
894 |
699 |
|
Intestinal Anti-Infective Antidiarrhoeals |
11,761 |
17.1 |
6.1 |
848 |
809 |
839 |
746 |
|
Hepatic Protectors, Lipotropics |
10,198 |
19.4 |
5.3 |
787 |
777 |
722 |
590 |
|
Anti-Diabetic |
1,56,947 |
6.8 |
100.0 |
12,980 |
12,242 |
12,008 |
10,768 |
|
Oral Antidiabetics |
1,21,912 |
6.4 |
77.7 |
10,160 |
9,543 |
9,359 |
8,259 |
|
Human Insulin Premix |
10,544 |
3.3 |
6.7 |
823 |
851 |
865 |
847 |
|
Insulin Analogues Basal |
8,957 |
11.0 |
5.7 |
728 |
666 |
614 |
611 |
|
Insulin Analogues Premix |
4,306 |
2.9 |
2.7 |
350 |
342 |
358 |
356 |
|
Insulin Analogues Rapid |
3,494 |
16.6 |
2.2 |
276 |
261 |
237 |
218 |
|
Vitamins / Minerals / Nutrients |
1,49,626 |
16.9 |
100.0 |
11,477 |
11,381 |
10,652 |
9,293 |
|
Traditional Antioxidants (Multivit / Multimineral) |
25,841 |
28.8 |
17.3 |
1,773 |
1,939 |
1,533 |
1,328 |
|
Calcium Products |
24,920 |
9.3 |
16.7 |
2,075 |
1,897 |
1,994 |
1,789 |
|
Other Vitamins |
22,673 |
22.3 |
15.2 |
1,625 |
1,684 |
1,458 |
1,243 |
|
B Complex |
15,079 |
10.8 |
10.1 |
1,158 |
1,168 |
1,146 |
963 |
|
Protein Supplements |
10,251 |
21.0 |
6.9 |
761 |
771 |
677 |
564 |
|
Source: AIOCD-AWACS, Ind-Ra |
|||||||
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)
.jpg)
